In particular, only a few studies support the development of BC resistance to ETs as a result of a lack in ERα function induced by the homozygous deletion of the ESR1 gene or LOH with inactivating mutations in the remaining allele [28,29,30]. This evidence concerns the gene ESR1 and breast cancer.